Bank of America’s Day One Biopharmaceuticals DAWN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.28M | Sell |
965,423
-81,333
| -8% | -$529K | ﹤0.01% | 3125 |
|
|
2025
Q1 | $8.3M | Buy |
1,046,756
+1,026,222
| +4,998% | +$8.14M | ﹤0.01% | 2829 |
|
|
2024
Q4 | $260K | Sell |
20,534
-171,660
| -89% | -$2.17M | ﹤0.01% | 5117 |
|
|
2024
Q3 | $2.68M | Buy |
192,194
+14,528
| +8% | +$202K | ﹤0.01% | 3658 |
|
|
2024
Q2 | $2.45M | Buy |
177,666
+50,077
| +39% | +$690K | ﹤0.01% | 3648 |
|
|
2024
Q1 | $2.11M | Sell |
127,589
-32,295
| -20% | -$534K | ﹤0.01% | 3706 |
|
|
2023
Q4 | $2.33M | Sell |
159,884
-58,717
| -27% | -$857K | ﹤0.01% | 3510 |
|
|
2023
Q3 | $2.68M | Buy |
218,601
+5,129
| +2% | +$62.9K | ﹤0.01% | 3338 |
|
|
2023
Q2 | $2.55M | Sell |
213,472
-20,118
| -9% | -$240K | ﹤0.01% | 3371 |
|
|
2023
Q1 | $3.12M | Buy |
233,590
+109,117
| +88% | +$1.46M | ﹤0.01% | 3398 |
|
|
2022
Q4 | $2.68M | Sell |
124,473
-31,732
| -20% | -$683K | ﹤0.01% | 3436 |
|
|
2022
Q3 | $3.13M | Buy |
156,205
+126,498
| +426% | +$2.53M | ﹤0.01% | 3281 |
|
|
2022
Q2 | $532K | Buy |
29,707
+23,857
| +408% | +$427K | ﹤0.01% | 4711 |
|
|
2022
Q1 | $58K | Buy |
5,850
+165
| +3% | +$1.64K | ﹤0.01% | 6324 |
|
|
2021
Q4 | $96K | Buy |
5,685
+5,201
| +1,075% | +$87.8K | ﹤0.01% | 6067 |
|
|
2021
Q3 | $11K | Sell |
484
-216
| -31% | -$4.91K | ﹤0.01% | 6634 |
|
|
2021
Q2 | $16K | Buy |
+700
| New | +$16K | ﹤0.01% | 6369 |
|